Year |
Citation |
Score |
2019 |
Bansal S, Murthy KG, Fitzgerald J, Schwartz BL, Joiner WM. Reduced transfer of visuomotor adaptation is associated with aberrant sense of agency in schizophrenia. Neuroscience. PMID 31228588 DOI: 10.1016/J.Neuroscience.2019.06.012 |
0.71 |
|
2019 |
McCarron KK, Dasgupta MK, Campbell CA, Hull AE, Namazi S, Adams AH, Allen NJ, Bloeser KJ, Thomas LA, Reinhard MJ, Scholten JD, Schwartz BL. Social rehabilitation for military veterans with traumatic brain injury, psychological trauma, and chronic neuropsychiatric symptoms: Intervention development and initial outcomes. Psychiatric Rehabilitation Journal. PMID 31070444 DOI: 10.1037/prj0000361 |
0.494 |
|
2018 |
Schwartz B, Teslovich T, You X, Cho J, Schooler N, Kokkinos P, Vaidya C. An Exploratory Study of Exercise-related Effects on Memory and Hippocampal Connectivity in Schizophrenia. Clinical Schizophrenia & Related Psychoses. PMID 29944414 DOI: 10.3371/Csrp.Scwo.061518 |
0.415 |
|
2018 |
Bansal S, Bray LCJ, Schwartz BL, Joiner WM. Transsaccadic Perception Deficits in Schizophrenia Reflect the Improper Internal Monitoring of Eye Movement Rather Than Abnormal Sensory Processing. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. 3: 168-177. PMID 29529412 DOI: 10.1016/J.Bpsc.2017.06.004 |
0.721 |
|
2017 |
Reinhard M, Allen N, Wong LM, Schwartz BL. Neuropsychological measurement of inhibitory control in posttraumatic stress disorder: An exploratory antisaccade paradigm. Journal of Clinical and Experimental Neuropsychology. 1-11. PMID 28349778 DOI: 10.1080/13803395.2017.1301389 |
0.675 |
|
2017 |
Bansal S, Schwartz B, Joiner W. M40. Sensory Prediction Error Deficits in Schizophrenia: A Multi Behavioral Approach Schizophrenia Bulletin. 43: S226-S226. DOI: 10.1093/Schbul/Sbx022.039 |
0.71 |
|
2013 |
Deutsch SI, Schwartz BL, Schooler NR, Brown CH, Rosse RB, Rosse SM. Targeting alpha-7 nicotinic neurotransmission in schizophrenia: a novel agonist strategy. Schizophrenia Research. 148: 138-44. PMID 23768813 DOI: 10.1016/J.Schres.2013.05.023 |
0.391 |
|
2013 |
Schwartz BL, Vaidya CJ, Shook D, Deutsch SI. Neural basis of implicit memory for socio-emotional information in schizophrenia. Psychiatry Research. 206: 173-80. PMID 23123045 DOI: 10.1016/J.Psychres.2012.10.005 |
0.429 |
|
2013 |
Schwartz BL, Metcalfe J. Tip-of-the-tongue (TOT) states: Mechanisms and metacognitive control Tip-of-the-Tongue States and Related Phenomena. 15-31. DOI: 10.1017/CBO9781139547383.002 |
0.36 |
|
2011 |
Schwartz BL, Metcalfe J. Tip-of-the-tongue (TOT) states: retrieval, behavior, and experience. Memory & Cognition. 39: 737-49. PMID 21264637 DOI: 10.3758/S13421-010-0066-8 |
0.399 |
|
2010 |
Schwartz BL, Vaidya CJ, Howard JH, Deutsch SI. Attention to gaze and emotion in schizophrenia. Neuropsychology. 24: 711-20. PMID 20873932 DOI: 10.1037/A0019562 |
0.434 |
|
2010 |
Katz E, Burket JA, Rosse SM, Rosse RB, Schwartz BL, Deutsch SI. Cerebral ventricular asymmetry and ventriculomegaly interact to increase risk for schizophrenia: A case report and recommendation for routine fetal sonography Cns Spectrums. 15: 574-578. DOI: 10.1017/S1092852900000547 |
0.401 |
|
2009 |
Schwartz BL, Parker ES, Rosse RB, Deutsch SI. Recognition memory probes affect what is remembered in schizophrenia. Psychiatry Research. 167: 21-7. PMID 19339054 DOI: 10.1016/j.psychres.2008.04.005 |
0.498 |
|
2009 |
Deutsch SI, Burket JA, Rosse RB, Schwartz BL. Genetic variation of chromosome 1q42: Etiologic mechanism of congenital disorders of neuronal migration and synaptogenesis Current Psychiatry Reviews. 5: 236-249. DOI: 10.2174/157340009789542178 |
0.388 |
|
2008 |
Deutsch SI, Schwartz BL, Schooler NR, Rosse RB, Mastropaolo J, Gaskins B. First administration of cytidine diphosphocholine and galantamine in schizophrenia: a sustained alpha7 nicotinic agonist strategy. Clinical Neuropharmacology. 31: 34-9. PMID 18303489 DOI: 10.1097/wnf.0b013e31806462ba |
0.343 |
|
2008 |
Deutsch SI, Rosse RB, Schwartz BL, Schooler NR, Gaskins BL, Long KD, Mastropaolo J. Effects of CDP-choline and the combination of CDP-choline and galantamine differ in an animal model of schizophrenia: development of a selective alpha7 nicotinic acetylcholine receptor agonist strategy. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 18: 147-51. PMID 17656074 DOI: 10.1016/j.euroneuro.2007.05.008 |
0.395 |
|
2006 |
Schwartz BL, Mastropaolo J, Rosse RB, Mathis G, Deutsch SI. Imitation of facial expressions in schizophrenia. Psychiatry Research. 145: 87-94. PMID 17074400 DOI: 10.1016/j.psychres.2005.12.007 |
0.419 |
|
2005 |
Marvel CL, Schwartz BL, Howard DV, Howard JH. Implicit learning of non-spatial sequences in schizophrenia. Journal of the International Neuropsychological Society : Jins. 11: 659-67. PMID 16248901 DOI: 10.1017/S1355617705050861 |
0.702 |
|
2005 |
Söderlund H, Parker ES, Schwartz BL, Tulving E. Memory encoding and retrieval on the ascending and descending limbs of the blood alcohol concentration curve. Psychopharmacology. 182: 305-17. PMID 16160875 DOI: 10.1007/s00213-005-0096-2 |
0.697 |
|
2004 |
Marvel CL, Schwartz BL, Rosse RB. A quantitative measure of postural sway deficits in schizophrenia. Schizophrenia Research. 68: 363-72. PMID 15099618 DOI: 10.1016/j.schres.2003.09.003 |
0.732 |
|
2004 |
Marvel CL, Schwartz BL, Isaacs KL. Word production deficits in schizophrenia. Brain and Language. 89: 182-91. PMID 15010249 DOI: 10.1016/S0093-934X(03)00366-3 |
0.696 |
|
2003 |
Schwartz BL, Howard DV, Howard JH, Hovaguimian A, Deutsch SI. Implicit learning of visuospatial sequences in schizophrenia. Neuropsychology. 17: 517-33. PMID 12959517 DOI: 10.1037/0894-4105.17.3.517 |
0.398 |
|
2003 |
Deutsch SI, Schwartz BL, Rosse RB, Mastropaolo J, Marvel CL, Drapalski AL. Adjuvant topiramate administration: a pharmacologic strategy for addressing NMDA receptor hypofunction in schizophrenia. Clinical Neuropharmacology. 26: 199-206. PMID 12897641 DOI: 10.1097/00002826-200307000-00010 |
0.727 |
|
2003 |
Maril A, Simons JS, Mitchell JP, Schwartz BL, Schacter DL. Feeling-of-knowing in episodic memory: an event-related fMRI study. Neuroimage. 18: 827-36. PMID 12725759 DOI: 10.1016/S1053-8119(03)00014-4 |
0.414 |
|
2003 |
Schwartz B, Parker E, Hovaguimian A, Williams A, Rosse R, Deutsch S. Context-dependent memory impairment in schizophrenia: Analysis of the frontal dysfunction hypothesis Schizophrenia Research. 60: 182-183. DOI: 10.1016/S0920-9964(03)81078-2 |
0.471 |
|
2003 |
Marvel C, Schwartz B, Rosse R. Postural stability in schizophrenia Schizophrenia Research. 60: 145. DOI: 10.1016/S0920-9964(03)80959-3 |
0.715 |
|
2002 |
Schwartz BL, Marvel CL, Drapalski A, Rosse RB, Deutsch SI. Configural processing in face recognition in schizophrenia. Cognitive Neuropsychiatry. 7: 15-39. PMID 16528403 DOI: 10.1080/13546800143000113 |
0.677 |
|
2002 |
Schwartz BL, Parker ES, Deutsch SI, Rosse RB, Kaushik M, Isaac A. Source monitoring in alcoholism. Journal of Clinical and Experimental Neuropsychology. 24: 806-17. PMID 12424654 DOI: 10.1076/jcen.24.6.806.8406 |
0.325 |
|
2001 |
Drapalski AL, Rosse RB, Peebles RR, Schwartz BL, Marvel CL, Deutsch SI. Topiramate improves deficit symptoms in a patient with schizophrenia when added to a stable regimen of antipsychotic medication. Clinical Neuropharmacology. 24: 290-4. PMID 11586114 DOI: 10.1097/00002826-200109000-00006 |
0.71 |
|
2001 |
Deutsch SI, Rosse RB, Schwartz BL, Mastropaolo J. A revised excitotoxic hypothesis of schizophrenia: therapeutic implications. Clinical Neuropharmacology. 24: 43-9. PMID 11290881 DOI: 10.1097/00002826-200101000-00008 |
0.396 |
|
2000 |
Rosenberg PB, Rosse RB, Schwartz BL, Deutsch SI. Nefazodone in the adjunctive therapy of schizophrenia: an open-label exploratory study. Clinical Neuropharmacology. 23: 222-5. PMID 11020129 DOI: 10.1097/00002826-200007000-00011 |
0.384 |
|
1999 |
Schwartz BL, Rosse RB, Johri S, Deutsch SI. Visual scanning of facial expressions in schizophrenia. The Journal of Neuropsychiatry and Clinical Neurosciences. 11: 103-6. PMID 9990565 DOI: 10.1176/Jnp.11.1.103 |
0.418 |
|
1998 |
Rosse RB, Schwartz BL, Johri S, Deutsch SI. Visual scanning of faces correlates with schizophrenia symptomatology. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 22: 971-9. PMID 9789881 DOI: 10.1016/S0278-5846(98)00056-6 |
0.457 |
|
1997 |
Schwartz BL, Fay-McCarthy M, Kendrick K, Rosse RB, Deutsch SI. Effects of nifedipine, a calcium channel antagonist, on cognitive function in schizophrenic patients with tardive dyskinesia. Clinical Neuropharmacology. 20: 364-70. PMID 9260735 DOI: 10.1097/00002826-199708000-00009 |
0.357 |
|
1997 |
Deutsch SI, Rosse RB, Schwartz BL, Fay-McCarthy M, Rosenberg PB, Fearing K. Methylene blue adjuvant therapy of schizophrenia. Clinical Neuropharmacology. 20: 357-63. PMID 9260734 DOI: 10.1097/00002826-199708000-00008 |
0.448 |
|
1997 |
Deutsch SI, Rosse RB, Schwartz BL. Histamine H2 Receptor Antagonists in Schizophrenia Cns Drugs. 8: 276-284. DOI: 10.2165/00023210-199708040-00002 |
0.476 |
|
1997 |
McCarthy MF, Kendrick KA, Rosse RB, Schwartz BL, Peace T, Wyatt RJ, Deutsch SI. The effect of nifedipine on akathisia and agitation in patients with movement disorders Schizophrenia Research. 24: 208. DOI: 10.1016/S0920-9964(97)82597-2 |
0.383 |
|
1997 |
Schwartz B, Fay-McCarthy M, Kendrick K, Rosse R, Deutsch S. Effect of nifedipine on motor skill learning in schizophrenia Schizophrenia Research. 24: 125. DOI: 10.1016/S0920-9964(97)82352-3 |
0.408 |
|
1996 |
Schwartz BL, Rosse RB, Veazey C, Deutsch SI. Impaired motor skill learning in schizophrenia: implications for corticostriatal dysfunction. Biological Psychiatry. 39: 241-8. PMID 8645770 DOI: 10.1016/0006-3223(95)00130-1 |
0.394 |
|
1996 |
Schwartz BL, Hashtroudi S, Herting RL, Schwartz P, Deutsch SI. d-Cycloserine enhances implicit memory in Alzheimer patients. Neurology. 46: 420-4. PMID 8614505 DOI: 10.1212/Wnl.46.2.420 |
0.311 |
|
1994 |
Deutsch SI, Rosse RB, Schwartz BL, Banay-Schwartz M, McCarthy MF, Johri SK. L-tyrosine pharmacotherapy of schizophrenia: preliminary data. Clinical Neuropharmacology. 17: 53-62. PMID 8149360 DOI: 10.1097/00002826-199402000-00006 |
0.386 |
|
1993 |
Schwartz BL, Rosse RB, Deutsch SI. Limits of the processing view in accounting for dissociations among memory measures in a clinical population. Memory & Cognition. 21: 63-72. PMID 8433649 DOI: 10.3758/Bf03211165 |
0.336 |
|
1993 |
Rosse RB, Schwartz BL, Kim SY, Deutsch SI. Correlation between antisaccade and Wisconsin Card Sorting Test performance in schizophrenia. The American Journal of Psychiatry. 150: 333-5. PMID 8422090 DOI: 10.1016/0006-3223(92)90484-H |
0.455 |
|
1993 |
Metcalfe J, Schwartz BL, Joaquim SG. The cue-familiarity heuristic in metacognition. Journal of Experimental Psychology. Learning, Memory, and Cognition. 19: 851-61. PMID 8345327 DOI: 10.1037/0278-7393.19.4.851 |
0.393 |
|
1993 |
Deutsch S, Rosse R, Schwartz B, Fay-McCarthy M, Collins J. Efficacy of L-tyrosine adjuvant therapy in the treatment of schizophrenia Schizophrenia Research. 9: 236-237. DOI: 10.1016/0920-9964(93)90524-M |
0.374 |
|
1993 |
Schwartz B, Rosse R, Epstein P, Friedman L, Deutsch S. Memory for temporal order in the list discrimination paradigm in schizophrenia Schizophrenia Research. 9: 187-188. DOI: 10.1016/0920-9964(93)90380-2 |
0.451 |
|
1993 |
Rosse R, Schwartz B, Deutsch S. Affect recognition performance correlates with oculomotor functioning in schizophrenia Schizophrenia Research. 9: 165-166. DOI: 10.1016/0920-9964(93)90313-8 |
0.463 |
|
1992 |
Schwartz BL, Metcalfe J. Cue familiarity but not target retrievability enhances feeling-of-knowing judgments. Journal of Experimental Psychology. Learning, Memory, and Cognition. 18: 1074-83. PMID 1402711 DOI: 10.1037/0278-7393.18.5.1074 |
0.427 |
|
1992 |
Rosse RB, Schwartz BL, Zlotolow S, Banay-Schwartz M, Trinidad AC, Peace TD, Deutsch SI. Effect of a low-tryptophan diet as an adjuvant to conventional neuroleptic therapy in schizophrenia. Clinical Neuropharmacology. 15: 129-41. PMID 1350512 DOI: 10.1097/00002826-199204000-00007 |
0.408 |
|
1992 |
Schwartz BL, Rosse RB, Deutsch SI. Toward a neuropsychology of memory in schizophrenia. Psychopharmacology Bulletin. 28: 341-51. PMID 1296215 |
0.361 |
|
1991 |
Rosse RB, Schwartz BL, Mastropaolo J, Goldberg RL, Deutsch SI. Subtype diagnosis in schizophrenia and its relation to neuropsychological and computerized tomography measures. Biological Psychiatry. 30: 63-72. PMID 1892964 DOI: 10.1016/0006-3223(91)90071-S |
0.307 |
|
1991 |
Rosse RB, Schwartz BL, Davis RE, Deutsch SI. An NMDA intervention strategy in schizophrenia with "low-dose" milacemide. Clinical Neuropharmacology. 14: 268-72. PMID 1829980 DOI: 10.1097/00002826-199106000-00012 |
0.392 |
|
1991 |
Schwartz BL, Deutsch LH, Cohen C, Warden D, Deutsch SI. Memory for temporal order in schizophrenia. Biological Psychiatry. 29: 329-39. PMID 1674663 DOI: 10.1016/0006-3223(91)90218-B |
0.465 |
|
1990 |
Rosse RB, Schwartz BL, Leighton MP, Davis RE, Deutsch SI. An open-label trial of milacemide in schizophrenia: an NMDA intervention strategy. Clinical Neuropharmacology. 13: 348-54. PMID 2145067 DOI: 10.1097/00002826-199008000-00010 |
0.402 |
|
1989 |
Deutsch SI, Mastropaolo J, Schwartz BL, Rosse RB, Morihisa JM. A "glutamatergic hypothesis" of schizophrenia. Rationale for pharmacotherapy with glycine. Clinical Neuropharmacology. 12: 1-13. PMID 2540909 DOI: 10.1097/00002826-198902000-00001 |
0.476 |
|
Show low-probability matches. |